Journal article
Genetic mapping of novel modifiers for ApcMin induced intestinal polyps’ development using the genetic architecture power of the collaborative cross mice
- Abstract:
- Abstract Background Familial adenomatous polyposis is an inherited genetic disease, characterized by colorectal polyps. It is caused by inactivating mutations in the Adenomatous polyposis coli (Apc) gene. Mice carrying a nonsense mutation in the Apc gene at R850, which is designated Apc Min/+ (Multiple intestinal neoplasia), develop intestinal adenomas. Several genetic modifier loci of Min (Mom) were previously mapped, but so far, most of the underlying genes have not been identified. To identify novel modifier loci associated with Apc Min/+ , we performed quantitative trait loci (QTL) analysis for polyp development using 49 F1 crosses between different Collaborative Cross (CC) lines and C57BL/6 J-Apc Min/+ mice. The CC population is a genetic reference panel of recombinant inbred lines, each line independently descended from eight genetically diverse founder strains. C57BL/6 J-Apc Min/+ males were mated with females from 49 CC lines. F1 offspring were terminated at 23 weeks and polyp counts from three sub-regions (SB1–3) of small intestinal and colon were recorded. Results The number of polyps in all these sub-regions and colon varied significantly between the different CC lines. At 95% genome-wide significance, we mapped nine novel QTL for variation in polyp number, with distinct QTL associated with each intestinal sub-region. QTL confidence intervals varied in width between 2.63–17.79 Mb. We extracted all genes in the mapped QTL at 90 and 95% CI levels using the BioInfoMiner online platform to extract, significantly enriched pathways and key linker genes, that act as regulatory and orchestrators of the phenotypic landscape associated with the Apc Min/+ mutation. Conclusions Genomic structure of the CC lines has allowed us to identify novel modifiers and confirmed some of the previously mapped modifiers. Key genes involved mainly in metabolic and immunological processes were identified. Future steps in this analysis will be to identify regulatory elements – and possible epistatic effects – located in the mapped QTL
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.6MB, Terms of use)
-
- Publisher copy:
- 10.1186/s12864-021-07890-x
- Publication website:
- https://www.research.ed.ac.uk/files/226611716/s12864_021_07890_x.pdf
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- 10.13039/100004440
- Grant:
- Wellcome Trust grants 090532/Z/09/Z, 085906/Z/08/Z, 083573/Z/07/Z, and 075491/Z/04
+ Israeli Science foundation
More from this funder
- Funder identifier:
- 10.13039/501100003977
- Grant:
- 429/09, 961/15 and 1085/18
+ Cancer Biology Research Center, Tel Aviv University
More from this funder
- Funder identifier:
- 10.13039/501100011600
- Publisher:
- BioMed Central
- Journal:
- BMC Genomics More from this journal
- Volume:
- 22
- Issue:
- 1
- Pages:
- 566-566
- Article number:
- 566
- Publication date:
- 2021-07-22
- DOI:
- EISSN:
-
1471-2164
- ISSN:
-
1471-2164
- Language:
-
English
- Keywords:
- Pubs id:
-
1345538
- Local pid:
-
pubs:1345538
- Source identifiers:
-
W3186877660
- Deposit date:
-
2026-05-08
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record